Skip to Content

Join the 'Schizophrenia' group to help and get support from people like you.

Schizophrenia News

Related terms: Catatonic Schizophrenia, Disorganized Schizophrenia, Paranoid Schizophrenia, Residual Schizophrenia, Schizophrenia, catatonic, Schizophrenia, disorganized, Schizophrenia, paranoid, Schizophrenia, residual, Schizophrenia, undifferentiated, Undifferentiated Schizophrenia

FDA Medwatch Alert: Paliperidone Extended-Release Tablets 3mg by Teva Pharmaceuticals: Recall - Dissolution Test Failure

Posted 9 days ago by Drugs.com

ISSUE: Teva Pharmaceuticals USA, Inc. (Teva) initiated a voluntary recall to retail-level on 05/31/2017 for one lot of Paliperidone Extended-Release Tablets, 3mg, 90 count bottles, lot 1160682A, expiration 6/2018, NDC 0591-3693-19, that was distributed under the Actavis Pharma Inc. label. In coordination with FDA, Teva is extending this recall to the consumer/user level.  This recall is being carried out due to failing test results for dissolution. Teva cannot at this time exclude the potential for additional tablets to be below specification. Taking a product for the treatment of schizophrenia and schizoaffective disorders that has failed dissolution could result in less drug being absorbed. If two or more consecutive dosing regimens are with affected product, a failure to maintain therapeutic levels could occur, which could reduce effectiveness in treating a patient’s mental and/or moo ... Read more

Related support groups: Schizophrenia, Schizoaffective Disorder, Invega, Invega Sustenna, Paliperidone, Invega Trinza

FDA Approves Two-Month Aristada for Treatment of Schizophrenia

Posted 7 Jun 2017 by Drugs.com

DUBLIN--(BUSINESS WIRE)--Jun. 6, 2017-- Alkermes plc (NASDAQ: ALKS) today announced that the U.S. Food and Drug Administration (FDA) has approved two-month Aristada (aripiprazole lauroxil) extended-release injectable suspension for the treatment of schizophrenia. Aristada is now FDA-approved in four doses and three dosing duration options (441 mg, 662 mg or 882 mg once monthly, 882 mg once every six weeks and 1064 mg once every two months) and can be initiated at any dose or interval, offering an unprecedented range of flexibility to patients and healthcare providers. The new two-month dose is expected to be available in mid-June. “We designed Aristada to offer flexibility to meet the real-world needs of patients suffering from schizophrenia and the healthcare professionals providing their care. As the first and only long-acting atypical antipsychotic approved in three dosing durations ... Read more

Related support groups: Schizophrenia, Aripiprazole, Aristada

Chronic Pain Common in Adults With Depression, Anxiety

Posted 6 Jun 2017 by Drugs.com

TUESDAY, June 6, 2017 – Chronic pain afflicts about half of adults who have anxiety or depression, a new study finds. More than 5,000 adults in Brazil diagnosed with anxiety or mood disorders such as depression and bipolar disorder were asked about other health problems. Among those with a mood disorder, half reported chronic pain; 33 percent, respiratory diseases; 10 percent, heart disease; 9 percent, arthritis; and 7 percent, diabetes. Among those with anxiety, 45 percent reported chronic pain; 30 percent, respiratory diseases; and 11 percent each for arthritis and heart disease. Adults with two or more chronic diseases had an increased risk of a mood or anxiety disorder. High blood pressure was associated with both disorders at 23 percent, according to the Columbia University study published online June 1 in the Journal of Affective Disorders. Senior author Dr. Silvia Martins said ... Read more

Related support groups: Pain, Depression, Anxiety, Generalized Anxiety Disorder, Bipolar Disorder, Suboxone, Oxycodone, Anxiety and Stress, Lexapro, Zoloft, Hydrocodone, Cymbalta, Tramadol, Percocet, Methadone, OxyContin, Effexor, Prozac, Vicodin, Norco

'Recovery-Oriented' Talk Therapy May Help Curb Schizophrenia

Posted 6 Jun 2017 by Drugs.com

TUESDAY, June 6, 2017 – A type of talk therapy may provide lasting benefits for schizophrenia patients, a new study suggests. This approach is called recovery-oriented cognitive therapy. The study of 60 patients found those who received this therapy showed major improvements compared to those who received standard treatment, said researcher Paul Grant and his colleagues at the University of Pennsylvania. Schizophrenia is a serious mental illness. People with low-functioning schizophrenia are often isolated and disengaged from the outside world, lacking any future goals. In recovery-oriented cognitive therapy, a therapist helps the patient identify goals – like getting a specific job, reconnecting with family, or living independently. The therapist then works with the patient to overcome challenges and prevent relapse. Study participants had schizophrenia or schizoaffective disorder. ... Read more

Related support groups: Seroquel, Abilify, Lithium, Schizophrenia, Latuda, Zyprexa, Risperidone, Risperdal, Schizoaffective Disorder, Seroquel XR, Quetiapine, Geodon, Saphris, Olanzapine, Haldol, Invega, Haloperidol, Aripiprazole, Rexulti, Clozapine

City Life Tough on Teens' Mental Health

Posted 23 May 2017 by Drugs.com

TUESDAY, May 23, 2017 – City life seems to take a toll on the adolescent mind, new research suggests. The study included more than 2,000 18-year-olds in England and Wales who were interviewed about psychotic experiences (such as hearing voices and feeling extremely paranoid) since age 12. The research team from King's College London and Duke University found that teens raised in large cities were over 40 percent more likely to report psychotic experiences than those who grew up in rural areas. "These findings highlight the importance of early, preventative strategies for reducing psychosis risk and suggests that adolescents living in threatening neighborhoods within cities should be made a priority," said study co-senior author Helen Fisher. She is from the Institute of Psychiatry, Psychology & Neuroscience at King's College. "If we intervene early enough – for example by offering ... Read more

Related support groups: Schizophrenia, Schizoaffective Disorder, Psychosis, Psychiatric Disorders, Drug Psychosis, Depressive Psychosis

Women Aren't Better at Reading People's Faces After All

Posted 19 May 2017 by Drugs.com

FRIDAY, May 19, 2017 – When it comes to spotting a familiar face, men are just as gifted as women, a new study suggests. The finding contradicts the widely held belief that women are better at recognizing faces and reading facial expressions than men are, the Penn State researchers said. "There has been common lore in the behavioral literature that women do better than men in many types of face-processing tasks, such as face recognition and detecting and categorizing facial expressions, although, when you look in the empirical literature, the findings are not so clear-cut," said researcher Suzy Scherf. She is an assistant professor of psychology and neuroscience. "I went into this work fully expecting to see an effect of biological sex on the part of the observer in facial recognition – and we did not find any. And we looked really hard," she added in a Penn State news release. Facial ... Read more

Related support groups: Depression, Generalized Anxiety Disorder, Bipolar Disorder, Social Anxiety Disorder, Schizophrenia, Paranoid Disorder, Schizoaffective Disorder, Dysthymia, Psychiatric Disorders, Diagnosis and Investigation

Just 1 in 5 Mentally Ill Women Gets Cervical Cancer Screenings

Posted 17 Apr 2017 by Drugs.com

MONDAY, April 17, 2017 – Cervical cancer screening rates are much lower among women with severe mental illness than among other women, a new study finds. "The results of this very large study indicate that we need to better prioritize cervical cancer screening for these high-risk women with severe mental illnesses," said study senior author Dr. Christina Mangurian. She's an associate professor of clinical psychiatry at the University of California, San Francisco. Researchers reviewed 2010-11 California Medicaid data for the study. Of the women with severe mental illness, 42 percent had some form of schizophrenia. Almost a third of the women had major depression. Nearly one in five had bipolar disorder, and the rest had anxiety or another disorder. The study showed that 20 percent of women with severe mental illness were screened for cervical cancer. But 42 percent of women in the ... Read more

Related support groups: Depression, Bipolar Disorder, Major Depressive Disorder, Obsessive Compulsive Disorder, Post Traumatic Stress Disorder, Schizophrenia, Mania, Borderline Personality Disorder, Schizoaffective Disorder, Sexual Dysfunction, SSRI Induced, Autism, Psychosis, Psychiatric Disorders, Asperger Syndrome, Dissociative Identity Disorder, Neurotic Depression, Body Dysmorphic Disorder, Neurosis, Excoriation Disorder, Dependent Personality Disorder

Infections More Common in People With Schizophrenia

Posted 4 Apr 2017 by Drugs.com

MONDAY, April 3, 2017 – People with schizophrenia may face an increased risk for serious infections, a new study suggests. "The preliminary data results suggest that individuals with schizophrenia have higher prevalence of all types of severe infections compared to the background population," study author Monika Pankiewicz-Dulacz, from the University of Southern Denmark, and colleagues wrote. "Clinicians should be aware that people with schizophrenia are the risk group for severe infections. General guidelines and suggestions regarding prevention of severe infections among schizophrenia patients are needed, and they should address a wide range of areas including hygiene, diet, activities, medications, treatment of comorbid [co-existing] conditions and vaccinations," the researchers concluded. However, the study's findings only show a link between schizophrenia and certain infections, ... Read more

Related support groups: Infections, Urinary Tract Infection, Bacterial Infection, Schizophrenia, Schizoaffective Disorder, Bacterial Skin Infection, Tuberculosis, Skin and Structure Infection, Viral Infection, Infectious Hepatitis, Wound Infection

Autism Greatly Boosts Kids' Injury Risk, Especially for Drowning

Posted 21 Mar 2017 by Drugs.com

TUESDAY, March 21, 2017 – Children with autism are at extremely high risk of drowning compared to other kids, a new study reveals. Analysis of death records found that kids with an autism spectrum disorder are 160 times more likely to die from drowning compared with the general pediatric population, the researchers reported. Children diagnosed with autism – usually between 2 and 3 years of age – need swimming lessons as soon as possible, even before they start other therapies that will improve the long-term quality of their lives, said senior author Dr. Guohua Li. "Pediatricians and parents should immediately help enroll the child in swimming classes, before any behavioral therapy, speech therapy or occupational therapy," said Li. He is a professor of epidemiology at Columbia University's Mailman School of Public Health in New York City. "Swimming ability for kids with autism is an ... Read more

Related support groups: Seizures, Attention-Deficit Hyperactivity Disorder (ADHD), Schizophrenia, Autism, Seizure Prevention, Seizure Prophylaxis, Asperger Syndrome

Drinking, Drug Abuse Doubles Veterans' Suicide Risk: Study

Posted 17 Mar 2017 by Drugs.com

FRIDAY, March 17, 2017 – U.S. veterans with substance abuse problems have a higher risk of suicide than veterans who don't, new research suggests. The study looked at more than 4 million veterans, and found that drug or alcohol problems affected 8 percent of males and 3 percent of females. These veterans had a more than twofold increased risk of suicide compared with those without a substance use disorder. The suicide rate was especially high among female veterans with drug or alcohol problems. These women had a more than five times greater rate of suicide than female veterans who did not have substance abuse problems. "We hope these findings will help clinicians and health systems care for people with substance use disorders, with mental health conditions, and with both – and focus suicide prevention efforts accordingly," said lead study author Kipling Bohnert. Bohnert is an ... Read more

Related support groups: Depression, Anxiety, Bipolar Disorder, Anxiety and Stress, Major Depressive Disorder, Opiate Dependence, Post Traumatic Stress Disorder, Schizophrenia, Drug Dependence, Psychosis, Dysthymia, Psychiatric Disorders, Substance Abuse, Toxic Reactions Incl Drug and Substance Abuse, Depressive Psychosis

Blood Test Might Someday Distinguish Early Depression, Schizophrenia

Posted 14 Mar 2017 by Drugs.com

TUESDAY, March 14, 2017 – It's often difficult for doctors to tell the difference between depression and schizophrenia, especially early on. Now, researchers say they're on the trail of a blood test that might be able to do just that. "This is the first objective, physiological marker for two major psychiatric disorders that, once fully developed into a clinical test, can allow for earlier and more accurate diagnosis, and selection of more appropriate medications for patients," study co-author Dr. Handan Gunduz-Bruce said in a news release from The Physiological Society. Gunduz-Bruce is a schizophrenia researcher at the Yale School of Medicine. One psychiatrist agreed that such a test is needed. "It can be very difficult to diagnose depression and schizophrenia, especially when they onset in the adolescent years," said Dr. Scott Krakower, assistant chief of psychiatry at Zucker ... Read more

Related support groups: Depression, Major Depressive Disorder, Schizophrenia, Dysthymia, Diagnosis and Investigation

Patients Often Reject Drug-Only Psychiatric Treatment

Posted 6 Mar 2017 by Drugs.com

MONDAY, March 6, 2017 – Mental health patients are more likely to reject treatment if it involves only drugs, a new study finds. Some experts believe talk therapy should be the first treatment option for many mental health disorders. The new finding – from a review of 186 prior studies – supports that stance, the researchers said. "Patients often desire an opportunity to talk with and work through their problems with a caring individual who might be able to help them better face their emotional experiences," said study co-author Roger Greenberg. He's a professor of psychology at the State University of New York's Upstate Medical University. Greenberg and his colleagues analyzed 186 studies of patients who sought help for mental health conditions. Overall, the average treatment refusal rate was more than 8 percent. Patients offered drug therapy alone were almost twice as likely to ... Read more

Related support groups: Depression, Anxiety, Generalized Anxiety Disorder, Bipolar Disorder, Panic Disorder, Anxiety and Stress, Lexapro, Zoloft, Cymbalta, Effexor, Prozac, Celexa, Seroquel, Major Depressive Disorder, Citalopram, Paxil, Sertraline, Abilify, Post Traumatic Stress Disorder, Pristiq

Little Weight Gain in Pregnancy Tied to Schizophrenia Risk in Kids: Study

Posted 23 Feb 2017 by Drugs.com

WEDNESDAY, Feb. 22, 2017 – Gaining too little weight during pregnancy may increase the odds that a child will develop schizophrenia later in life, Swedish researchers suggest. Past research has shown that pregnant women in areas of famine are more likely to have children who suffer from mental disorders, including schizophrenia. The new study found a 30 percent increased risk for schizophrenia in children of underweight women in an industrialized country. "Even in a wealthy, well-fed population like Sweden, there are still mothers unable to meet the nutritional requirements for safe pregnancies," lead researcher Euan Mackay said. Mackay is a research assistant at the Karolinska Institute's division of epidemiology of mental health in Stockholm. Mackay cautioned that these findings cannot prove that women who don't gain enough weight during pregnancy are putting their child at risk for ... Read more

Related support groups: Seroquel, Abilify, Weight Loss, Schizophrenia, Latuda, Zyprexa, Risperidone, Risperdal, Schizoaffective Disorder, Seroquel XR, Geodon, Quetiapine, Saphris, Olanzapine, Psychosis, Delivery, Invega, Aripiprazole, Rexulti, Clozapine

No, Your Cat Isn't a Threat to Your Mental Health

Posted 22 Feb 2017 by Drugs.com

TUESDAY, Feb. 21, 2017 – Cat owners can breathe a sigh of relief: Your feline's litter box likely won't put your family's mental health at risk. New British research challenges earlier beliefs that parasites in cat droppings might be linked to schizophrenia, obsessive-compulsive disorder and other mental health issues. "The message for cat owners is clear: There is no evidence that cats pose a risk to children's mental health," said study author Dr. Francesca Solmi, of University College London Psychiatry. Cats are carriers of an infectious parasite called Toxoplasma gondii (T. gondii). They may pass this infection on to humans through their feces. The researchers behind this study wanted to know if contact with cats during childhood raised risk for mental illness. To find out, the researchers followed nearly 5,000 people born in the early 1990s until they were 18 years old. ... Read more

Related support groups: Obsessive Compulsive Disorder, Schizophrenia, Psychosis, Psychiatric Disorders, Toxoplasmosis, Labor and Delivery including Augmentation, Toxoplasmosis - Prophylaxis

Sunovion’s Latuda (lurasidone) Receives FDA Approval to Treat Adolescents with Schizophrenia

Posted 30 Jan 2017 by Drugs.com

MARLBOROUGH, Mass.--(BUSINESS WIRE)--January 28, 2017 Sunovion Pharmaceuticals Inc. (Sunovion) today announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for Latuda (lurasidone HCI) for the treatment of schizophrenia in adolescents aged 13 to 17 years. Latuda is also approved in the U.S. for the treatment of adults with schizophrenia and for the treatment of adults with major depressive episodes associated with bipolar I disorder (bipolar depression) as monotherapy and as adjunctive therapy with lithium or valproate. “The impact on development and poor prognosis frequently associated with schizophrenia that begins in adolescence underscores the need for treatment that is both well-tolerated and effective,” said Robert Findling, M.D., M.B.A., Vice President of Psychiatric Services and Research at the Kennedy Krieger Institute, D ... Read more

Related support groups: Schizophrenia, Latuda, Lurasidone

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Schizoaffective Disorder, Psychiatric Disorders

Related Drug Support Groups

Seroquel, Abilify, Latuda, Zyprexa, risperidone, Risperdal, Seroquel XR, Geodon, quetiapine, view more... Saphris, olanzapine, Invega, aripiprazole, Rexulti, clozapine, Thorazine, Clozaril, Invega Sustenna, ziprasidone, Fanapt, chlorpromazine, Zyprexa Zydis, Vraylar, paliperidone, Risperdal Consta, asenapine, Navane, Stelazine, Mellaril, thioridazine, loxapine, iloperidone, lurasidone, thiothixene, brexpiprazole, Zyprexa Intramuscular, trifluoperazine, Risperdal M-Tab, Abilify Maintena, Sparine, reserpine, Abilify Discmelt, Moban, Clopine, Loxitane IM, Aristada, Versacloz, Invega Trinza, Adasuve, Zyprexa Relprevv, FazaClo, mesoridazine, Loxitane, cariprazine, molindone, promazine, Ormazine, Clozapine Synthon, Serentil, Mellaril-S, Zaponex, Denzapine, Loxitane C